�鶹ӰԺ

NASA—Research led by Tobias Niederwieser, assistant research professor in CU �鶹ӰԺ's BioServe Space Technologies, is exploring how microgravity can enable the large-scale production of high-quality blood stem cells aboard the International Space Station. The work could improve treatments for blood cancers, immune disorders and other diseases by creating more reliable supplies of stem cells for patients on Earth.

CU �鶹ӰԺ Today—�鶹ӰԺ researchers have developed a method to activate and sustain glowing bioluminescent algae using simple chemical solutions, opening the door to future technologies such as living sensors and autonomous systems that operate in dark environments.

CU �鶹ӰԺ Renewable and Sustainable Energy Institute (RASEI)—Imagine a display that harvests ambient light when it is not actively in use, offsetting some of its own energy consumption. The materials physics shows that this is possible.

CU �鶹ӰԺ College of Engineering and Applied Science—Researchers at the �鶹ӰԺ are developing a new class of “entangled materials” inspired by the surprising strength of a tangled ball of office staples.

CU �鶹ӰԺ College of Arts and Sciences—Research suggests that disrupted or fragmented sleep after a traumatic brain injury not only interferes with the healing process but also has long-term consequences for brain health. Rachel Rowe, an assistant professor of integrative physiology at the �鶹ӰԺ, has investigated this question in a recent study linking low-quality sleep following traumatic brain injury to cognitive impairment, persistent inflammation and delayed healing.

CU �鶹ӰԺ Today—CU �鶹ӰԺ researchers have discovered an appetite-suppressing compound in python blood that helps the snakes consume enormous meals and go months without eating yet remain metabolically healthy. The research, a collaboration with scientists at Stanford Medicine and Baylor universities, could inform new weight loss therapies that promote satiety without the nausea and muscle loss that can come with existing drugs.

CU �鶹ӰԺ Today—Supported by a new five-year, up to $25 million award from the Advanced Research Projects Agency for Health (ARPA-H) Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) program, a team of CU �鶹ӰԺ, MIT, Harvard and Columbia researchers is working to develop 3D-printed liver tissue made of human cells and able to be transplanted into anyone without their body rejecting it.

Life Science Newswire–Cirena has secured a license to the �鶹ӰԺ’s patented RNA synthesis technology, enabling reliable synthesis of long RNA needed to support rapidly developing applications in CRISPR, functional genomics, and emerging RNA-therapeutic modalities.

CU �鶹ӰԺ College of Engineering & Applied Science—William Frantz didn’t walk away with the top prize at this year’s Lab Venture Challenge (LVC), but his research may still be a winner for future cancer patients. Frantz is developing microscopic droplets designed to help doctors track radiation therapy in real time, technology that could one day make cancer treatment more precise and less harmful, particularly for pediatric patients.

ScienceDaily—CU �鶹ӰԺ researchers have designed microscopic “racetracks” that trap and amplify light with exceptional efficiency. By using smooth curves inspired by highway engineering, they reduced energy loss and kept light circulating longer inside the device. Fabricated with sub-nanometer precision, the resonators rank among the top performers made from chalcogenide glass. The technology could lead to compact sensors, microlasers, and advanced quantum systems.